Molecular Diagnostics
Biomarker Improves Diagnosis of Esophageal Cancer
A biomarker has been discovered that has the potential to improve the diagnosis, prognosis, and treatment of Esophageal Squamous Cell Carcinoma, the major histological form of esophageal cancer, a leading cause of cancer death worldwide. More...23 Jan 2014
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Gel Cards
DG Gel Cards
Blood Glucose Test Strip
AutoSense Test
In Other News
Biopsy Test Predicts Aggressive form of Skin Cancer
MicroRNAs Predict Likelihood of Breast Cancer Metastasis
Blood Test Locates Gene Defects Linked to Cancer
Horizon and AstraZeneca Announce Oncology Agreement
Blood-Based Biomarkers Validated for Mild Cognitive Impairment
Determination of Circulating CPN Cleavage Peptides Enables Early Diagnosis of Breast Cancer
Molecular Diagnostics Optimized for Breast Cancer Tissue Samples
Cervical Cancer Genomic Study Completed
Causal Role Found for Common Genetic Variant in Narcolepsy
Collaboration to Examine the Utility of KRAS Mutations in Urine
Known Lung Cancer Oncogenes Drive Colorectal Cancer
Myopathy Diagnosis Improved by New Gene Mutation
Analysis of Saliva DNA Suggested for Screening Stroke-Linked Mutation
Newly Identified Immune Receptor Activates B Cells in Autoimmunity
Dominant Gene Mutations Causes Van der Woude Syndrome
New Genetic Risk Factor for Type 2 Diabetes Uncovered
Genome Sequencing Detects Defects in Human Oocytes
Standardized Assays Developed to Quantify Human Proteins
Gene Mutation Identified as Diagnostic Target for Insulinoma
Rare Gene Variants Doubles Alzheimer's Disease Risk
Genetic Signature Identifies Patients with Aggressive Triple-Negative Cancers
Melanoma Diagnostic Distinguishes Between Malignant and Benign Skin Lesions
Rapid Whole Genome Sequencing Detects Microorganisms from Clinical Samples
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
